Crystal DSilva - uventia

Crystal DSilva

Crystal DSilva

Crystal D’Silva

Associate Director – Preclinical Toxicology

Baxter-Healthcare

Crystal D’Silva is based in Brussels, Belgium and currently holds the position of Pre-Clinical Technical Lead at Baxter. She is responsible for contributing to strategic Pre-Clinical R&D cross-function, cross-region, and cross-disciplinary programs with global impact across Baxter’s business segments and innovation platforms. She provides industry expertise in shaping external scientific committee guidelines (e.g., ISO 10993, FDA, ICH) and regional compendia in the areas of Pre-Clinical Sciences. She is also a European Registered Toxicologist (ERT) and a member of the European Society of Toxicology In Vitro (ESTIV) and the Belgian Society of Toxicology and Ecotoxicology (BELTOX). She has a PhD in Medical Biophysics from the University of Toronto in collaboration with the Princess Margaret Cancer Centre and the Hospital for Sick Children (Ontario, Canada).

SPEAKED ABOUT:
Genotoxic-Impurities-Nitrosamines-Beyond
December 4, 2024
Meeting with subject matter experts to evaluate different points of view on how to solve the problems associated with mutagenic impurities. Recording of 2 days event sessions [13 video sessions].
Expired

DAY 1: December 4th, 2024

SESSION: Toxicological Risk Assessment of Nitrosamines – Challenges and Perspectives

◆  Overview of toxicological risk assessment of nitrosamines.

◆  Comparison between agency- and literature-published acceptable intake values.

◆  Challenges with the current state of affairs and future perspectives.

Speaker Details
Speaker Details